Meihua Biological Technology Co.,Ltd
 

Address:shanhuafu,Dajing Street,Qiaoxi District,Shijiazhuang City,Hebei Province,China

 
Home > Products > SRAMS > Views
GW501516

 

GW501516

GW501516 (also known as GW-501,516GW1516GSK-516 and on the black market as Endurobol[1]) is a PPARδ receptor agonist that was invented in a collaboration between Ligand Pharmaceuticals and GlaxoSmithKline in the 1990s, was entered into clinical development as a drug candidate for metabolic diseases and cardiovascular diseases, and was abandoned in 2007 because animal testing showed that the drug caused cancer to develop rapidly in several organs.

 

GW501516
GW501,516.svg
Clinical data
Pregnancy
category
  • N/A
Routes of
administration
oral
ATC code
  • none
Legal status
Legal status
  • AU: Unscheduled
  • UK: Unscheduled
  • US: Unscheduled
Identifiers
CAS Number
  • 317318-70-0
PubChem CID
  • 9803963
IUPHAR/BPS
  • 2687
ChemSpider
  • 7979723
UNII
  •  
ChEBI
  •  
ChEMBL  
Chemical and physical data
Formula C21H18F3NO3S2
Molar mass 453.498 g/mol

 

 

Commodity message
Product Name:   
Content:  *
Your e-mail:  * Example: example@mail.com
Verification code:  *  
   
 
 
Our Address :No.105 Block C, Zhongshanhuafu,Dajing Street,Qiaoxi District,Shijiazhuang City,Hebei Province,China